COMP <GO>
XBIT vs VRCA // DIVIDEND YIELD & FCF PAYOUT SAFETY
XBiotech Inc. (NASDAQ) VS. Verrica Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: XBIT 1
— VRCA 2
■ METRIC PARITY
LAST: $1.88 (-3.09%) • MKT CAP: $59.1M
dividend-safety
0.00%
LAST: $3.35 (-2.05%) • MKT CAP: $58.8M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XBIT VS. VRCA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XBIT | VRCA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -34.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -50.30% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 180.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | VRCA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.8 | 34.1 | -0.34 | VRCA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $59.1M | $58.8M | $394.8K | XBIT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XBIT REV | VRCA REV | XBIT GROSS % | VRCA GROSS % | XBIT FCF | VRCA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $35.6M | — | — | -$40.2M | -$17.6M |
| FY 2024 | $0 | $7.6M | — | 65.6% | -$32.3M | -$61.0M |
| FY 2023 | $0 | $5.1M | — | — | -$18.7M | -$38.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XBIT // BETA —
VRCA // BETA —